Awards 2022. 08. 03

MIT technology Review -2021 TR50

Innorna has the proprietary core mRNA delivery technology and innovation capability on LNP delivery system.  Innorna has developed LNPs for a variety of application approaches. The liver-target LNPs are world-leading. Recently, Innorna has entered into a strategic collaboration with Beigene for mRNA therapy and delivery technology.


Keyword 5000

Innorna’s proprietary LNP technology platform is capable of designing and constructing tens of thousands of ionizable phospholipids and screening out the best LNPs for different treatment approaches. Libraries containing over 5000 LNPs has been constructed.